Dr Guillaume Grisay introduces the DE-ESCALATE trial
Watch this highly informative interview in which Dr Guillaume Grisay introduces the DE-ESCALATE trial in a conversation with Dr Alicia Morgans at GU ASCO 2024. GU ASCO stands for the 2024 American Society of Clinical Oncology Genitourinary cancers symposium held in San Francisco between January 25th and 27th. https://www.urotoday.com/video-lectures/prostate-cancer/video/3875-the-de-escalate-trial-intermittently-stopping-prostate-cancer-treatments-to-improve-quality-of-life-guillaume-grisay.html
Three new EORTC clinical trials funded by the EU
Brussels, April 24, 2023 – The European Commission has approved the funding of three new research projects coordinated by EORTC. Thanks to these grants, EORTC will perform three innovative pragmatic clinical trials optimising treatments for patients with refractory cancers starting summer of 2023. Public funding is essential to address clinically relevant questions with no commercial interest […]
